The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, extended his congratulations to the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, and His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister, on the success of the 1447 AH Hajj season, which was marked by integrated services, exemplary performance, and comprehensive care provided to the guests of Allah.

The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, extended his warmest congratulations to the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, and His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister, on the occasion of Eid al-Adha; praying to Allah to bless the Kingdom, and the Arab and Islamic nations with goodness and prosperity.

The Saudi Food and Drug Authority (SFDA) has granted Novo Nordisk Breakthrough designation to (FREHEMGO), which is indicated as a long-term routine prophylaxis of bleeding episodes in all age groups patients with hemophilia A with or without FVIII inhibitors.

H.E. Mr. Fahad bin Abdulrahman Al-Jalajel, Minister of Health and Chairman of the Board of Directors of the Saudi Food and Drug Authority (SFDA), visited the SFDA's Hajj Operations Center in Makkah today. The visit aimed to ensure the efficiency of services and evaluate ongoing efforts to enhance the safety of products provided to pilgrims during the Hajj season.

The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, conducted an inspection tour of several facilities within the SFDA's jurisdiction in the Makkah region. This visit was part of a comprehensive effort to evaluate the readiness of regulatory and field operations prior to the Hajj season 1447 AH.

During the tour, Dr. Aljadhey reviewed the preparedness of key regulatory procedures designed to ensure the safety, quality, and compliance of all food, pharmaceutical, and medical products with Saudi Arabia’s standards.

The Saudi Food and Drug Authority (SFDA) has revealed the results of its pre-Hajj campaign for the 1447 AH Hajj season, which targeted establishments under its supervision across the Makkah and Madinah regions. The campaign demonstrated advanced levels of regulatory readiness and operational efficiency, reflecting high compliance among facilities and significantly enhancing the safety of food, drugs, and medical products provided to pilgrims.

The Saudi Food and Drug Authority's (SFDA) Hajj Operations Center continues its round-the-clock operations from its headquarters in Makkah during the 1447 AH Hajj season, as part of a comprehensive regulatory framework aimed at enhancing field preparedness and expediting response times, thereby ensuring the safety of food, medicine, medical devices, and supplies provided to pilgrims.

In a landmark move to safeguard the health of millions, the Saudi Food and Drug Authority (SFDA) and the Organisation of Islamic Cooperation (OIC) have forged a strategic partnership to launch a comprehensive global campaign titled “Safe Medicines, Safe Hajj Journey.” This initiative represents a unified effort across 57 nations to prioritize medication safety and public health during the world’s largest annual gathering.

The Saudi Food and Drug Authority (SFDA) has deployed a sophisticated system of advanced technologies and modern digital tools to support its field teams and optimize oversight efficiency for facilities under its supervision during the Hajj season. These efforts are part of a broader strategy to enhance operational readiness and ensure the highest safety standards for the pilgrims.

The Saudi Food and Drug Authority (SFDA) has announced the full readiness of its laboratories for the 1447 AH Hajj season. The SFDA has implemented intensive operational plans to safeguard pilgrims and enhance emergency response efficiencies related to food and drug safety. These measures include 24/7 laboratory operations and increased capacity to manage the high seasonal workload, all while maintaining the highest international standards.